Title | The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Pomerantz MM, Li F, Takeda DY, Lenci R, Chonkar A, Chabot M, Cejas P, Vazquez F, Cook J, Shivdasani RA, Bowden M, Lis R, Hahn WC, Kantoff PW, Brown M, Loda M, Long HW, Freedman ML |
Journal | Nat Genet |
Volume | 47 |
Issue | 11 |
Pagination | 1346-51 |
Date Published | 2015 Nov |
ISSN | 1546-1718 |
Keywords | Binding Sites, Carcinogenesis, Cell Line, Tumor, Cell Transformation, Neoplastic, Chromatin Immunoprecipitation, Cluster Analysis, Genome-Wide Association Study, Hepatocyte Nuclear Factor 3-alpha, Homeodomain Proteins, Humans, Immunoblotting, Kaplan-Meier Estimate, Male, Prostate, Prostatic Neoplasms, Protein Binding, Receptors, Androgen, RNA Interference, Sequence Analysis, DNA, Transcriptome |
Abstract | Master transcription factors interact with DNA to establish cell type identity and to regulate gene expression in mammalian cells. The genome-wide map of these transcription factor binding sites has been termed the cistrome. Here we show that the androgen receptor (AR) cistrome undergoes extensive reprogramming during prostate epithelial transformation in man. Using human prostate tissue, we observed a core set of AR binding sites that are consistently reprogrammed in tumors. FOXA1 and HOXB13 colocalized at the reprogrammed AR binding sites in human tumor tissue. Introduction of FOXA1 and HOXB13 into an immortalized prostate cell line reprogrammed the AR cistrome to resemble that of a prostate tumor, functionally linking these specific factors to AR cistrome reprogramming. These findings offer mechanistic insights into a key set of events that drive normal prostate epithelium toward transformation and establish the centrality of epigenetic reprogramming in human prostate tumorigenesis. |
DOI | 10.1038/ng.3419 |
Alternate Journal | Nat Genet |
PubMed ID | 26457646 |
PubMed Central ID | PMC4707683 |
Grant List | P50 CA090381 / CA / NCI NIH HHS / United States U01CA176058 / CA / NCI NIH HHS / United States R01CA193910 / CA / NCI NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States R01 CA193910 / CA / NCI NIH HHS / United States U01 CA176058 / CA / NCI NIH HHS / United States U19CA148537 / CA / NCI NIH HHS / United States P50CA90381-11 / CA / NCI NIH HHS / United States |
Related Faculty:
Massimo Loda, M.D.